# Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects

> **NCT02708004** · PHASE1 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Aprocitentan
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02708004
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-01
- **Primary completion:** 2016-12-01
- **Final completion:** 2016-12-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02708004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02708004, "Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02708004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*